Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-20-013878

Options or other derivatives

  • Controller/Prin Fin&Acct Offic acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Austin Mark John Controller/Prin Fin&Acct Offic 2020-06-23 Grant or award · Stock Options (right to buy) +30,000 255,000 D: show line 1 in the form
Loading xslF345X03/rdgdoc.xml…